{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:17Z","timestamp":1791274637301,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Diagnosing cardiac sarcoidosis (CS) is challenging due to the variable presentation and the lack of consensus on optimal screening strategies. Early identification is critical to prevent adverse outcomes. This study evaluates the role of 18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET\/CT) in assessing CS in patients with no high-risk cardiac features and normal cardiac magnetic resonance (CMR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This retrospective, single-centre cohort included biopsy-confirmed extracardiac sarcoidosis patients who underwent CMR and FDG-PET\/CT. Patients with no high-risk cardiac features and normal CMR were included. The primary outcome was the diagnostic value of FDG-PET\/CT in the assessment for CS by a multi-disciplinary team (MDT). Secondary outcome included the occurrence of adverse cardiac events. In total, 305 (94.1%) patients were classified as \u2018unlikely CS\u2019, 17 (5.3%) as \u2018possible CS\u2019 and 2 (0.6%) as \u2018probable CS\u2019. Cardiac FDG uptake was observed in 69 of 324 patients (21.3%). Within the MDT, FDG-PET\/CT findings demonstrated limited diagnostic value, as 55.2% with uptake patterns suggestive of CS were ultimately classified as \u2018unlikely CS\u2019 based on other clinical and imaging findings. During a median follow-up of 38.1 months, the overall event rate was low: 15 events (3.4%; annualized 1.1%), with all five cardiac deaths occurring in the \u2018unlikely CS\u2019 group. Only five of 69 patients (7.2%) with cardiac FDG uptake experienced an adverse cardiac event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>FDG-PET\/CT offers limited diagnostic and prognostic value in sarcoidosis patients with no high-risk cardiac features and normal CMR. Our findings confirm that this population has a low risk of adverse cardiac events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeaf074","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T20:14:13Z","timestamp":1740946453000},"page":"830-837","source":"Crossref","is-referenced-by-count":2,"title":["The role of FDG-PET\/CT in assessing cardiac sarcoidosis with no high-risk cardiac features and normal CMR"],"prefix":"10.1093","volume":"26","author":[{"given":"F","family":"Shuduyeva","sequence":"first","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-9459","authenticated-orcid":false,"given":"A L M","family":"Bakker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]},{"name":"Department of Cardiology, Amphia Hospital , Breda ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Akdim","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R G M","family":"Keijsers","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Veltkamp","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, Utrecht University Medical Center , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Grutters","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, Utrecht University Medical Center , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]},{"name":"Division of Heart and Lungs, Utrecht University Medical Center , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Mathijssen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Antonius Hospital , Nieuwegein ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"2025043022565712700_jeaf074-B1","doi-asserted-by":"crossref","first-page":"106161","DOI":"10.1016\/j.rmed.2020.106161","article-title":"Current perspectives on the immunopathogenesis of sarcoidosis","volume":"173","author":"Lee","year":"2020","journal-title":"Respir Med"},{"key":"2025043022565712700_jeaf074-B2","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025043022565712700_jeaf074-B3","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology","volume":"50","author":"Cooper","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025043022565712700_jeaf074-B4","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"2025043022565712700_jeaf074-B5","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025043022565712700_jeaf074-B6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic accuracy of cardiac MRI versus FDG PET for cardiac sarcoidosis: a systematic review and meta-analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"key":"2025043022565712700_jeaf074-B7","doi-asserted-by":"crossref","first-page":"81 e9","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clin Radiol"},{"key":"2025043022565712700_jeaf074-B8","doi-asserted-by":"crossref","first-page":"1032444","DOI":"10.3389\/fnume.2022.1032444","article-title":"Recent advances in PET-MRI for cardiac sarcoidosis","volume":"2","author":"Munoz","year":"2022","journal-title":"Front Nucl Med"},{"key":"2025043022565712700_jeaf074-B9","doi-asserted-by":"crossref","first-page":"e220292","DOI":"10.1148\/ryct.220292","article-title":"Combined FDG PET\/MRI versus standard-of-care imaging in the evaluation of cardiac sarcoidosis","volume":"5","author":"Marschner","year":"2023","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2025043022565712700_jeaf074-B10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00408-024-00772-5","article-title":"Holter monitoring and cardiac biomarkers in screening for cardiac sarcoidosis","volume":"203","author":"Bakker","year":"2024","journal-title":"Lung"},{"key":"2025043022565712700_jeaf074-B11","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025043022565712700_jeaf074-B12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2025043022565712700_jeaf074-B13","doi-asserted-by":"crossref","first-page":"1900897","DOI":"10.1183\/13993003.00897-2019","article-title":"Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study","volume":"54","author":"Huitema","year":"2019","journal-title":"Eur Respir J"},{"key":"2025043022565712700_jeaf074-B14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"2025043022565712700_jeaf074-B15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12350-009-9179-5","article-title":"Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial","volume":"17","author":"Cheng","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"2025043022565712700_jeaf074-B16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"2025043022565712700_jeaf074-B17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2025043022565712700_jeaf074-B18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MCP.0000000000000892","article-title":"The role of PET in the management of sarcoidosis","volume":"28","author":"Vender","year":"2022","journal-title":"Curr Opin Pulm Med"},{"key":"2025043022565712700_jeaf074-B19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"key":"2025043022565712700_jeaf074-B20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41824-024-00218-4","article-title":"Discordant cardiac inflammation between 18F-FDG PET and CMR in patients with cardiac sarcoidosis","volume":"8","author":"Hutt","year":"2024","journal-title":"EJNMMI Rep"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf074\/62244179\/jeaf074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/5\/830\/62244179\/jeaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/26\/5\/830\/62244179\/jeaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:57:09Z","timestamp":1746068229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/26\/5\/830\/8051140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf074","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,3]]}}}